| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Benefit of Targeted DNA Sequencing in Advanced Non–Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests
|
Byeon, Seonggyu
|
|
|
21 |
3 |
p. e182-e190
|
artikel
|
| 2 |
Causes of Death and Hospitalization in Long-term Lung Cancer Survivors: A Population-based Appraisal
|
Wu, Geena X.
|
|
|
21 |
3 |
p. 204-213
|
artikel
|
| 3 |
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non–Small-Cell Lung Cancer
|
Patil, Tejas
|
|
|
21 |
3 |
p. e191-e204
|
artikel
|
| 4 |
Common Germline Mutations in a Patient With Multiple Primary Lung Cancers
|
Cytryn, Samuel
|
|
|
21 |
3 |
p. e212-e215
|
artikel
|
| 5 |
CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non–small-cell Lung Cancer
|
Owen, Benjamin
|
|
|
21 |
3 |
p. 225-231
|
artikel
|
| 6 |
Definitive Radiotherapy for Inoperable Stage IIB Non–small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness
|
Jacobs, Corbin D.
|
|
|
21 |
3 |
p. 238-246
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
21 |
3 |
p. A1
|
artikel
|
| 8 |
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy
|
Paajanen, Juuso
|
|
|
21 |
3 |
p. e142-e150
|
artikel
|
| 9 |
Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR + NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer
|
Xia, Hui
|
|
|
21 |
3 |
p. 247-254
|
artikel
|
| 10 |
Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities
|
Begnaud, Abbie
|
|
|
21 |
3 |
p. e164-e168
|
artikel
|
| 11 |
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA
|
Del Re, Marzia
|
|
|
21 |
3 |
p. 232-237
|
artikel
|
| 12 |
Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer
|
Duma, Narjust
|
|
|
21 |
3 |
p. e115-e129
|
artikel
|
| 13 |
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non–small-cell Lung Cancer Treated With Curative Intent
|
Rice, Stephanie R.
|
|
|
21 |
3 |
p. e130-e141
|
artikel
|
| 14 |
Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non–Small-Cell Lung Cancer
|
Zhang, Nasha
|
|
|
21 |
3 |
p. e151-e163
|
artikel
|
| 15 |
Long-Term Oncologic Outcomes After Robotic Lobectomy for Early-stage Non–Small-cell Lung Cancer Versus Video-assisted Thoracoscopic and Open Thoracotomy Approach
|
Kneuertz, Peter J.
|
|
|
21 |
3 |
p. 214-224.e2
|
artikel
|
| 16 |
Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer
|
Suresh, Karthik
|
|
|
21 |
3 |
p. e169-e170
|
artikel
|
| 17 |
Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized
|
Pham, Danh
|
|
|
21 |
3 |
p. e206-e211
|
artikel
|
| 18 |
Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery
|
Alberts, Leonie
|
|
|
21 |
3 |
p. e231-e232
|
artikel
|
| 19 |
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non–Small-Cell Lung Cancer in Clinical Practice
|
Steffen McLouth, Laurie E.
|
|
|
21 |
3 |
p. 255-263.e4
|
artikel
|
| 20 |
Patient-reported Outcomes With Stereotactic Body Radiotherapy and Surgery for Lung Cancer
|
Vogel, Jennifer
|
|
|
21 |
3 |
p. e229-e230
|
artikel
|
| 21 |
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation
|
Tanaka, Ichidai
|
|
|
21 |
3 |
p. 273-280.e4
|
artikel
|
| 22 |
Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179
|
Anouti, Bilal
|
|
|
21 |
3 |
p. 288-293
|
artikel
|
| 23 |
Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model
|
Wu, Xiao
|
|
|
21 |
3 |
p. e171-e181
|
artikel
|
| 24 |
Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”
|
Fukihara, Jun
|
|
|
21 |
3 |
p. e205
|
artikel
|
| 25 |
Second Primary Non–Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients
|
Budnik, Justin
|
|
|
21 |
3 |
p. 195-203
|
artikel
|
| 26 |
Table of Contents
|
|
|
|
21 |
3 |
p. A3-A4, A13, A15-A16
|
artikel
|
| 27 |
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non–Small-Cell Lung Cancer: A Clash of the Generations
|
Shah, Riyaz
|
|
|
21 |
3 |
p. e216-e228
|
artikel
|
| 28 |
Utility of Maximum CT Value in Predicting the Invasiveness of Pure Ground-Glass Nodules
|
Ichinose, Junji
|
|
|
21 |
3 |
p. 281-287
|
artikel
|
| 29 |
Validation of Independent Prognostic Value of Asphericity of 18F-Fluorodeoxyglucose Uptake in Non–Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent
|
Rogasch, Julian M.M.
|
|
|
21 |
3 |
p. 264-272.e6
|
artikel
|
Tijdschrift beschrijving